ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Myeloma in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Plasma Cell Cancer
Hematologic Cancer
Lymphoma
Leukemia
Cancer
Smoldering Multiple Myeloma
Non-Hodgkin Lymphoma

Multiple Myeloma trials near Cincinnati, OH, USA:

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients...

Enrolling
Multiple Myeloma
Drug: Teclistamab
Drug: Talquetamab

Phase 2

SCRI Development Innovations

Cincinnati, Ohio, United States of America and 15 other locations

This is an open-label, multi-site, Phase II randomized trial with response-adaptive design for newly diagnosed multiple myeloma (ND...

Enrolling
Multiple Myeloma, Newly Diagnosed
Multiple Myeloma (MM)
Drug: Elranatamab
Drug: Lenalidomide

Phase 2

SCRI Development Innovations

Cincinnati, Ohio, United States of America and 2 other locations

This is a Phase I dose-finding study of FT576 as monotherapy and in combination with the monoclonal antibody daratumumab in multiple myeloma...

Active, not recruiting
Multiple Myeloma
Myeloma
Drug: Cyclophosphamide
Drug: Bendamustine

Phase 1

Fate Therapeutics
Fate Therapeutics

Cincinnati, Ohio, United States of America and 13 other locations

Multiple Myeloma (MM) is a cancer of the blood's plasma cells ( blood cell). The cancer is typically found in the bones and bone ma...

Enrolling
Multiple Myeloma
Drug: ABBV-383

Phase 1

TeneoOne

Cincinnati, Ohio, United States and 40 other locations

of care therapy (SOCT) in participants with relapsed/refractory multiple myeloma who have received 1 to 3 prior lines of therapy, i...

Enrolling
Multiple Myeloma
Drug: Fludarabine
Drug: Cyclophosphamide

Phase 3

Gilead Sciences
Gilead Sciences

Cincinnati, Ohio, United States and 74 other locations

of CB-011, and to assess the effectiveness of CB-011 in treating multiple myeloma that has come back (relapsed) or that is no longe...

Enrolling
Relapsed/Refractory Multiple Myeloma
Biological: CB-011

Phase 1

Caribou Biosciences

Cincinnati, Ohio, United States of America and 15 other locations

of this study is to evaluate the effectiveness and safety of Arlocabtagene Autoleucel (BMS-986393) in participants with relapsed or refractory multiple...

Enrolling
Multiple Myeloma
Biological: Arlocabtagene Autoleucel (BMS-986393)

Phase 2

Juno Therapeutics

Cincinnati, Ohio, United States of America and 51 other locations

This open-label, randomized study for evaluating the efficacy and safety of single agent belantamab mafodotin when compared to pom/dex in participant...

Active, not recruiting
Multiple Myeloma
Drug: Belantamab mafodotin
Drug: Pom/dex (Pomalidomide plus low dose Dexamethasone)

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Cincinnati, Ohio, United States and 135 other locations

Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spon...

Enrolling
Multiple Myeloma
Drug: Carfilzomib
Drug: Etentamig

Phase 3

AbbVie
AbbVie

Cincinnati, Ohio, United States and 150 other locations

with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple...

Enrolling
Multiple Myeloma
Drug: Bortezomib
Drug: Dexamethasone

Phase 3

Celgene
Celgene

Cincinnati, Ohio, United States and 285 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems